LV10580A - Farmaceitiska kompozicija un tas iegusanas panemiens - Google Patents
Farmaceitiska kompozicija un tas iegusanas panemiensInfo
- Publication number
- LV10580A LV10580A LV940150A LV940150A LV10580A LV 10580 A LV10580 A LV 10580A LV 940150 A LV940150 A LV 940150A LV 940150 A LV940150 A LV 940150A LV 10580 A LV10580 A LV 10580A
- Authority
- LV
- Latvia
- Prior art keywords
- saturation
- ipriflavone
- tricalcium phosphate
- pharmaceutical composition
- combinations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/50—Preparations specially adapted for dental root treatment
- A61K6/54—Filling; Sealing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
- A61K6/69—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/831—Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
- A61K6/838—Phosphorus compounds, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/432—Inhibitors, antagonists
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Transplantation (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plastic & Reconstructive Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Dental Preparations (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9302230A HU212932B (en) | 1993-08-02 | 1993-08-02 | Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV10580A true LV10580A (lv) | 1995-04-20 |
| LV10580B LV10580B (en) | 1995-10-20 |
Family
ID=10983854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-94-150A LV10580B (en) | 1993-08-02 | 1994-07-29 | Pharmaceutical composition and process |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5571186A (lv) |
| EP (1) | EP0638321B1 (lv) |
| JP (1) | JP3500190B2 (lv) |
| KR (1) | KR950005313A (lv) |
| CN (1) | CN1208093C (lv) |
| AT (1) | ATE188129T1 (lv) |
| AU (1) | AU686632B2 (lv) |
| CA (1) | CA2129279A1 (lv) |
| DE (1) | DE69422346T2 (lv) |
| DK (1) | DK0638321T3 (lv) |
| ES (1) | ES2142893T3 (lv) |
| HU (1) | HU212932B (lv) |
| LV (1) | LV10580B (lv) |
| NZ (1) | NZ264152A (lv) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU9502198D0 (en) * | 1995-07-21 | 1995-09-28 | Chinoin Gyogyszer Es Vegyeszet | Novel indication |
| KR101542703B1 (ko) * | 2006-10-24 | 2015-08-06 | 크렘핀, 로리에 | 항-재흡수 및 골 형성 식이보충제 및 이의 사용 방법 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU162377B (lv) * | 1970-05-27 | 1973-02-28 | ||
| US3949085A (en) * | 1970-05-27 | 1976-04-06 | Chinoin Gyogyszer-Es Vegyeszeti Termakek Gyara Rt | Anabolic-weight-gain promoting compositions containing isoflavone derivatives and method using same |
| JPS59199630A (ja) * | 1983-04-26 | 1984-11-12 | Takeda Chem Ind Ltd | 卵巣機能低下症治療剤 |
| HU199444B (en) * | 1985-09-10 | 1990-02-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing 7-isopropoxy-isoflavone-cyclodextrene inclusion complex and pharmaceutical compositions therefrom |
| HU201474B (en) * | 1987-02-03 | 1990-11-28 | Tibor Balogh | Process for producing new dentriatrical composition |
| US5124325A (en) * | 1989-06-13 | 1992-06-23 | Kyorin Pharmaceutical Co., Ltd. | Therapeutic agents of metabolic bone disease |
| IT1241079B (it) * | 1990-03-23 | 1993-12-29 | Chiesi Farma Spa | Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico |
| US5164187A (en) * | 1990-04-05 | 1992-11-17 | Norian Corporation | Hydroxyapatite prosthesis coatings |
| IT1244697B (it) * | 1991-02-01 | 1994-08-08 | Chiesi Farma Spa | Associazione farmaceutica per la prevenzione e il trattamento dell'osteoporosi post-menopausale |
-
1993
- 1993-08-02 HU HU9302230A patent/HU212932B/hu active IP Right Revival
-
1994
- 1994-07-29 AU AU68810/94A patent/AU686632B2/en not_active Ceased
- 1994-07-29 US US08/282,753 patent/US5571186A/en not_active Expired - Lifetime
- 1994-07-29 LV LVP-94-150A patent/LV10580B/en unknown
- 1994-08-01 DK DK94111951T patent/DK0638321T3/da active
- 1994-08-01 AT AT94111951T patent/ATE188129T1/de not_active IP Right Cessation
- 1994-08-01 KR KR1019940019026A patent/KR950005313A/ko not_active Abandoned
- 1994-08-01 ES ES94111951T patent/ES2142893T3/es not_active Expired - Lifetime
- 1994-08-01 EP EP94111951A patent/EP0638321B1/en not_active Expired - Lifetime
- 1994-08-01 DE DE69422346T patent/DE69422346T2/de not_active Expired - Fee Related
- 1994-08-02 CA CA002129279A patent/CA2129279A1/en not_active Abandoned
- 1994-08-02 NZ NZ264152A patent/NZ264152A/en unknown
- 1994-08-02 CN CNB941161919A patent/CN1208093C/zh not_active Expired - Fee Related
- 1994-08-02 JP JP18141294A patent/JP3500190B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH07144018A (ja) | 1995-06-06 |
| DK0638321T3 (da) | 2000-06-19 |
| KR950005313A (ko) | 1995-03-20 |
| ATE188129T1 (de) | 2000-01-15 |
| EP0638321A1 (en) | 1995-02-15 |
| NZ264152A (en) | 1996-08-27 |
| LV10580B (en) | 1995-10-20 |
| HUT71253A (en) | 1995-11-28 |
| AU6881094A (en) | 1995-02-09 |
| JP3500190B2 (ja) | 2004-02-23 |
| DE69422346T2 (de) | 2000-07-27 |
| US5571186A (en) | 1996-11-05 |
| CN1105271A (zh) | 1995-07-19 |
| CA2129279A1 (en) | 1995-02-03 |
| CN1208093C (zh) | 2005-06-29 |
| EP0638321B1 (en) | 1999-12-29 |
| HU9302230D0 (en) | 1993-10-28 |
| HU212932B (en) | 1996-12-30 |
| ES2142893T3 (es) | 2000-05-01 |
| AU686632B2 (en) | 1998-02-12 |
| DE69422346D1 (de) | 2000-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE174872T1 (de) | Carbonierte hydroxyapatit-zusammensetzungen und ihre verwendungen | |
| AU8452991A (en) | 1-aryl-3-pyridinyl-2-propene-1-ones | |
| MX171177B (es) | Composicion para desinfectar sustratos | |
| DE69403656D1 (de) | Stabile, orale und absorbierbare therapeutische zusammensetzungen von nadh und nadph | |
| ATA186692A (de) | Pharmazeutische zusammensetzung | |
| CA2063273A1 (en) | Surfactant compositions and methods | |
| KR960700036A (ko) | 항골양 조성물(anticaries compositions) | |
| LV10580A (lv) | Farmaceitiska kompozicija un tas iegusanas panemiens | |
| NO913683L (no) | Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer. | |
| IT1240683B (it) | Composizione farmaceutica contenente egf | |
| DK0458950T3 (da) | Stabilisering af K2P pro | |
| AU629445B2 (en) | Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol | |
| DE3676640D1 (de) | Prazosin-pirbuterol-mischung zur bronchendilatation. | |
| AU8452791A (en) | 1-phenyl-3-aryl-2-propyne-1-ones | |
| AR246274A1 (es) | Polvo absorbible para espolvorear derivado de almidon. | |
| EP0286601A3 (en) | Powdered deodorant composition for shoes, in particular for sporting shoes | |
| DK0539465T3 (da) | Anvendelse af 20(R)-22-oxa-D-vitamin-analoger til fremstilling af et farmaceutisk præparat til behandling og/eller forebyggelse af hudaldring | |
| JPS55120510A (en) | Composition for oral cavity | |
| JPS55362A (en) | Dental cement | |
| BG100138A (en) | Bicyclic spiran compounds, methods for their preparation and perfume compositions containing them |